Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus(T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07486986
What this trial is testing

Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health

Who this might be right for
MenopauseSleep DisruptionT2DM
Ottawa Heart Institute Research Corporation 381
Post-approval studies (Phase 4)Study completedNCT04027530
What this trial is testing

Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseDiabetic Nephropathy+4 more
Amsterdam UMC, location VUmc 40
Early research (Phase 1)Study completedNCT01835730
What this trial is testing

Phase 1 Multicenter, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PhaseBio Pharmaceuticals Inc. 37
Testing effectiveness (Phase 2)Study completedNCT02581657
What this trial is testing

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
PhaseBio Pharmaceuticals Inc. 37
Not applicableStudy completedNCT07238257
What this trial is testing

Effectiveness of Digital Health Intervention on Community Health Care in Middle-aged and Older Population in Taiwan

Who this might be right for
Hypertension (HTN)Type 2 Diabetes Mellitus (T2DM)Hyperuricemia+4 more
Chang Gung Memorial Hospital 199
Post-approval studies (Phase 4)Study completedNCT01468519
What this trial is testing

Exploratory CSII Trial on Erectile Dysfunction in T2DM Patients

Who this might be right for
Diabetes Mellitus, Type 2Erectile Dysfunction
Jothydev's Diabetes and Research Centre 20
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Post-approval studies (Phase 4)Looking for participantsNCT06461377
What this trial is testing

The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy

Who this might be right for
Type 2 DiabetesDiabetes With Diabetic Autonomic Neuropathy (Diagnosis)
The First Affiliated Hospital with Nanjing Medical University 50
Not applicableStudy completedNCT01529216
What this trial is testing

Efficacy Study of the DIAMOND System to Treat Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
MetaCure Limited 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07796477
What this trial is testing

SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
CSPC Ouyi Pharmaceutical Co., Ltd. 240
Large-scale testing (Phase 3)Study completedNCT01042977
What this trial is testing

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease

Who this might be right for
Type 2 Diabetes MellitusCardiovascular DiseaseInadequate Glycaemic Control
AstraZeneca 964
Testing effectiveness (Phase 2)Study completedNCT05232071
What this trial is testing

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

Who this might be right for
NASH - Nonalcoholic SteatohepatitisDiabetes Mellitus, Type 2
Inventiva Pharma 39
Not applicableLooking for participantsNCT07398495
What this trial is testing

Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Sarcopenia
yueh chu wu 128
Testing effectiveness (Phase 2)Study completedNCT00885118
What this trial is testing

4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 100
Post-approval studies (Phase 4)Study completedNCT02280486
What this trial is testing

Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin

Who this might be right for
Type 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 388
Early research (Phase 1)Study completedNCT01013766
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 23
Not applicableNot Yet RecruitingNCT07019753
What this trial is testing

Experience With the Use of Continuous Glucose Monitoring (CGM) Devices in People With Type 2 Diabetes Mellitus

Who this might be right for
Patient SatisfactionContinuous Glucose MonitoringType 2 Diabetes Mellitus (T2DM)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 5
Not applicableStudy completedNCT02446054
What this trial is testing

Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease

Who this might be right for
Type II Diabetes Mellitus
Celio Technology Inc. 30
Not applicableLooking for participantsNCT06627322
What this trial is testing

A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)

Who this might be right for
Type 2 Diabetes
Kyu Chang Won 5,950
Not applicableWithdrawnNCT06861491
What this trial is testing

Student Pharmacist Non-Pharmacological Intervention on Type 2 Diabetes Management in Older Asian Adult Populations

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
University of California, San Francisco
Next Page